OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1714$9.2656

Ho Tung Chemical Corp

Commodity ChemicalsVerified

The company's capital structure shows a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. With cash and equivalents of TWD 2,279.27 million and total liabilities of TWD 12,807.82 million, the current ratio of 3.24 suggests strong short-term liquidity. However, the risk assessment flags a net cash position that is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 4.02% and a return on assets (ROA) of 1.96%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of TWD 1,211.25 million on revenue of TWD 24,021.497 million, is 5.04%, which is in line with the industry's median but does not suggest a competitive advantage. The company's revenue is distributed across five segments: chemical products, oil products, investment, cement, and construction. The chemical and oil products segments are likely the primary contributors to revenue, though the exact proportions are not disclosed. Geographically, the company operates in Taiwan, Mainland China, Southeast Asia, and other regions, but the revenue concentration by region is not specified in the available data. The outlook for the current fiscal year indicates a revenue growth trajectory, supported by the company's operating cash flow of TWD 1,126.97 million and free cash flow of TWD 1,211.099 million. However, the capital expenditure of TWD -310.031 million suggests a reduction in investment, which may affect long-term growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is minimal, as shares outstanding for both basic and diluted are identical at 981.683 million. No significant adjustments were applied to the valuation metrics, indicating that the financial data is clean and reliable. Recent events, including filings and transcripts, are not detailed in the provided data. However, the company's financial snapshot and valuation metrics suggest a stable but not high-growth business model.

30-day price · 1714+0.34 (+3.6%)
Low$9.02High$10.65Close$9.80As of22 May, 00:00 UTC
Profile
CompanyHo Tung Chemical Corp
Ticker1714.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ho Tung Chemical Corp is a Taiwan-based manufacturer and trader of chemical products, including paraffin hydrocarbon, acetylene, alkyl benzene, and diesel, with operations in chemical products, oil products, investment, cement, and construction segments.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 0.92 confidence.

The company's capital structure shows a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. With cash and equivalents of TWD 2,279.27 million and total liabilities of TWD 12,807.82 million, the current ratio of 3.24 suggests strong short-term liquidity. However, the risk assessment flags a net cash position that is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 4.02% and a return on assets (ROA) of 1.96%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of TWD 1,211.25 million on revenue of TWD 24,021.497 million, is 5.04%, which is in line with the industry's median but does not suggest a competitive advantage. The company's revenue is distributed across five segments: chemical products, oil products, investment, cement, and construction. The chemical and oil products segments are likely the primary contributors to revenue, though the exact proportions are not disclosed. Geographically, the company operates in Taiwan, Mainland China, Southeast Asia, and other regions, but the revenue concentration by region is not specified in the available data. The outlook for the current fiscal year indicates a revenue growth trajectory, supported by the company's operating cash flow of TWD 1,126.97 million and free cash flow of TWD 1,211.099 million. However, the capital expenditure of TWD -310.031 million suggests a reduction in investment, which may affect long-term growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is minimal, as shares outstanding for both basic and diluted are identical at 981.683 million. No significant adjustments were applied to the valuation metrics, indicating that the financial data is clean and reliable. Recent events, including filings and transcripts, are not detailed in the provided data. However, the company's financial snapshot and valuation metrics suggest a stable but not high-growth business model.
Key takeaways
  • The company maintains a conservative debt-to-equity ratio of 0.25, indicating a relatively low leverage position.
  • ROE of 4.02% and ROA of 1.96% suggest moderate profitability, in line with industry norms.
  • Strong liquidity is evident from a current ratio of 3.24, though the risk assessment notes a negative net cash position after debt.
  • Revenue is spread across five segments, with no clear concentration by region or product.
  • The company's capital expenditure is negative, signaling a potential reduction in investment for growth.
  • Low dilution risk is supported by identical basic and diluted shares outstanding.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$24.02B
Gross profit$2.51B
Operating income$1.21B
Net income$490.1M
R&D
SG&A
D&A
SBC
Operating cash flow$1.13B
CapEx-$310.0M
Free cash flow$1.21B
Total assets$25.00B
Total liabilities$12.81B
Total equity$12.19B
Cash & equivalents$2.28B
Long-term debt$3.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$9.26
Market cap$9.09B
Enterprise value$9.89B
P/E18.6
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income8.2
EV/OCF8.8
P/B0.8
P/Tangible book0.8
Tangible book$12.19B
Net cash-$799.8M
Current ratio3.2
Debt/Equity0.2
ROA2.0%
ROE4.0%
Cash conversion2.3%
CapEx/Revenue-1.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1714Activity
Op margin5.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin10.4%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity25.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 15:56 UTC#0151a8eb
Market quoteclose TWD 9.26 · shares 0.98B diluted
no public URL
2026-05-04 15:56 UTC#ac66fe8e
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 15:58 UTCJob: 6fa2e465